Skip to content

Evaluating the effect of dry cupping, and Aslaq capsule, on the infertility

Evaluating the effect of dry cupping, and Aslaq capsule, on the incidence of pregnancy in patients with infertility due to polycystic ovary syndrome

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180923041093N7
Enrollment
120
Registered
2022-07-04
Start date
2022-07-21
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility due to polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: cupping+ Letrozole- 2.5 mg letrozole tablets twice a day, on days 3 to 7 of menstruation. Moreover, from the seventh day of the menstrual cycle to the fourteenth da

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: PCOs based on Rotterdam criteria and diagnosing infertility fellowship Infertility with at least one year of unprotected intercourse Age between 18 and 35 years

Exclusion criteria

Exclusion criteria: Systemic disease requires serious therapeutic interventions premature ovarian failure Single ovarian cyst or breast cyst Endometriosis, Pelvic Adhesions, Tube Obstruction, Tube Abnormalities, and Hyperprolactinemia Infertility due to male factor

Design outcomes

Primary

MeasureTime frame
Time of pregnancy occurrence. Timepoint: After the intervention. Method of measurement: sonography or BHCG.

Secondary

MeasureTime frame
Menstrual pain. Timepoint: Monthly. Method of measurement: Visual analogue scale.;The length of the menstrual cycle. Timepoint: Monthly. Method of measurement: Time interval from the first day of menstrual bleeding to the last day of menstrual bleeding in a cycle. Based on the person's response to the questionnaire.;Ovulation rate. Timepoint: Monthly. Method of measurement: Ultrasonography.;Endometrial thickness. Timepoint: Monthly - Day 13 of the menstrual cycle. Method of measurement: Ultrasonography.;Follicle growth. Timepoint: Monthly - Day 13 of the menstrual cycle. Method of measurement: Ultrasonography.;Sexual function. Timepoint: At the beginning of the intervention, three and six months after the start of the intervention. Method of measurement: Female sexual function index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Sadat Hasheminasab

Zahedan University of Medical Sciences

hashemifa67@gmail.com+98 938 238 4249

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026